Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Addiction Medicine Expert Dr. Omar Manejwala Joins Catasys, Inc. (CATS)

|Includes: Catasys Inc. (CATS)

On Friday, Catasys, Inc. announced that addiction medicine expert Dr. Omar Manejwala has joined Catasys as Senior Vice President & Chief Medical Officer. In this capacity, Dr. Manejwala will be responsible for Catasys’ clinical affairs and continued clinical development of the OnTrak™ program. Dr. Manejwala is formerly of Hazelden, one of the world’s largest alcohol and drug dependence treatment centers.

Before joining Catasys, Dr. Manejwala was Medical Director for Hazelden Foundation. Prior to that, he served as associate medical director at The Farley Center at Williamsburg Place in Virginia, an addiction treatment center. He is a fellow of the American Psychiatric Association and a diplomate of the American Board of Addiction Medicine.

Dr. Manejwala is a graduate of the University of Maryland School of Medicine. He completed his residency at Duke University where he served as executive chief resident. Dr. Manejwala’s background also includes an MBA from the University of Virginia’s Darden School.

Dr. Manejwala has been interviewed on Good Morning America, 20/20, ABC World News Tonight, The CBS Early Show, and CBS Evening News with Katie Couric, ABC News Primetime, the UK’s Sky News, and the international RTL Network. The New York Times, Chicago Tribune, Los Angeles Times, and the UK’s Guardian have also featured him in articles.

Dr. Omar Manejwala said, “I am excited to be joining Catasys as Catasys is preparing to launch its latest health plan contract. The Company’s program is the leading edge in addressing addiction clinically and lowering the overall costs by addressing this chronic disease in an integrated medical and behavioral fashion over a 52-week period. With the Company now enrolling members under its health plan contracts we will be focusing on using the outcomes from these members to further the development of Catasys.”

Headquartered in Los Angeles, California, Catasys provides specialized health management services to health plans, employers and unions. They do this via a network of licensed and company managed health care providers. The design of the Catasys substance dependence program is to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long-term care coaching. This includes a proprietary treatment program for alcoholism and stimulant dependence.

For more information, visit catasyshealth.com

Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net